Notification
No new Notification messages
Niva Bupa Health Insurance IPO is Open!
Apply for the Niva Bupa Health Insurance IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
aspira pathlab & diagnostics l stock

Aspira Pathlab & Diagnostics L Share Price

61.75 1.93 (3.22%)
Nov 11 2024 03:26 PM Healthcare NSE: ASPIRA

Aspira Pathlab & Diagnostics L Share Price Update

As of the latest trading session, Aspira Pathlab & Diagnostics L share price is currently at 61.75, which is up by 1.93 from its previous closing. Today, the stock has fluctuated between 60.00 and 62.75. Over the past year, Aspira Pathlab & Diagnostics L has achieved a return of 57.00 %. In the last month alone, the return has been 42.19 %. Read More...

Aspira Pathlab & Diagnostics L Performance

Day Range

Low60.00 High62.75
61.75

52 Week Range

Low 25.00 High 59.82
61.75

Aspira Pathlab & Diagnostics L Share Price

540788

ASPIRA

img img img img
No Data Available

Open Price

62.51

Prev. Close

59.82

Volume (Shares)

6186.00

Total traded value

3.76

Upper Circuit

64.83

Lower Circuit

58.67

Note: The current prices & values are delayed, Login to your account for live updates.

Aspira Pathlab & Diagnostics L Fundamentals


(Standalone)

Market Cap (Cr) 63.60
PE Ratio (TTM) -31.16
Book Value / Share 5.06
Beta -0.17
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.02

Aspira Pathlab & Diagnostics L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 4.64
Operating Expense 4.74
Net Profit -0.02
Net Profit Margin (%) -0.43
Earnings Per Share (EPS) -0.02
EBITDA 0.44
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 3.82
Operating Expense 4.39
Net Profit -0.50
Net Profit Margin (%) -13.08
Earnings Per Share (EPS) -0.49
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 3.46
Operating Expense 4.31
Net Profit -0.74
Net Profit Margin (%) -21.38
Earnings Per Share (EPS) -0.72
EBITDA -0.27
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 3.32
Operating Expense 4.18
Net Profit -0.71
Net Profit Margin (%) -21.38
Earnings Per Share (EPS) -0.69
EBITDA -0.21
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 2.60
Operating Expense 3.42
Net Profit -0.72
Net Profit Margin (%) -27.69
Earnings Per Share (EPS) -0.70
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 13.20
Operating Expense 16.30
Net Profit -2.67
Net Profit Margin (%) -20.22
Earnings Per Share (EPS) -2.60
EBITDA -0.75
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 14.46
Operating Expense 14.87
Net Profit -0.09
Net Profit Margin (%) -0.62
Earnings Per Share (EPS) -0.09
EBITDA 1.92
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 19.54
Operating Expense 15.18
Net Profit 4.46
Net Profit Margin (%) 22.82
Earnings Per Share (EPS) 4.33
EBITDA 6.47
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 15.21
Operating Expense 14.03
Net Profit 1.38
Net Profit Margin (%) 9.07
Earnings Per Share (EPS) 1.45
EBITDA 3.71
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 8.42
Operating Expense 12.91
Net Profit -4.24
Net Profit Margin (%) -50.35
Earnings Per Share (EPS) -4.56
EBITDA -1.54
Effective Tax Rate (%) -0.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 5.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin -5.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 7.60
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.20
EBITDA Margin 13.28
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.64
ROE % 23.08
ROCE % 17.56
Total Debt to Total Equity 0.19
EBITDA Margin 33.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.29
ROE % 15.17
ROCE % 11.51
Total Debt to Total Equity 0.70
EBITDA Margin 24.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share -1.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.47
EBITDA Margin -18.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.38
Total Assets 14.70
Total Liabilities 14.70
Total Equity 10.14
Share Outstanding 10293000
Price to Book Ratio 6.11
Return on Assets (%) -18.16
Return on Capital (%) -23.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 17.34
Total Liabilities 17.34
Total Equity 12.75
Share Outstanding 10293000
Price to Book Ratio 3.66
Return on Assets (%) -0.51
Return on Capital (%) -0.65
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 18.13
Total Liabilities 18.13
Total Equity 12.78
Share Outstanding 10293000
Price to Book Ratio 8.48
Return on Assets (%) 24.58
Return on Capital (%) 32.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.18
Total Assets 11.77
Total Liabilities 11.77
Total Equity 8.31
Share Outstanding 10293000
Price to Book Ratio 8.66
Return on Assets (%) 11.72
Return on Capital (%) 14.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 14.33
Total Liabilities 14.33
Total Equity 3.80
Share Outstanding 9293000
Price to Book Ratio -31.65
Return on Assets (%) -29.58
Return on Capital (%) -39.74
Particulars MAR 2024 (Values in Cr)
Net Income -2.67
Cash from Operations 1.05
Cash from Investing 0.13
Cash from Financing -0.95
Net change in Cash 0.23
Free Cash Flow 1.31
Particulars MAR 2023 (Values in Cr)
Net Income -0.08
Cash from Operations -0.01
Cash from Investing 0.15
Cash from Financing -0.93
Net change in Cash -0.78
Free Cash Flow 0.11
Particulars MAR 2022 (Values in Cr)
Net Income 4.45
Cash from Operations 2.03
Cash from Investing -0.51
Cash from Financing -1.35
Net change in Cash 0.16
Free Cash Flow 2.62
Particulars MAR 2021 (Values in Cr)
Net Income 1.38
Cash from Operations 5.67
Cash from Investing -0.09
Cash from Financing -2.17
Net change in Cash 3.40
Free Cash Flow 5.79
Particulars MAR 2020 (Values in Cr)
Net Income -4.24
Cash from Operations -1.83
Cash from Investing 0.24
Cash from Financing 1.27
Net change in Cash -0.35
Free Cash Flow -1.79
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7420.90 90.19 14.23 106701.16 5122.60 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 53.59 0.00 3.36 100.44 44.00 / 107.94
SHREE PACETRONIX LTD. 130.00 20.93 3.48 46.79 118.00 / 368.70
TRANSGENE BIOTEK LTD. 6.55 0.00 4.63 49.63 5.38 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7420.90 95.02 13.02 106701.16 5122.60 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 39.07 0.00 -89.41 29.19 26.57 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5596.20 31.49 6.89 6122.24 2575.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 57.40
  • 26 Days 50.70
  • 10 Days 55.20
  • 50 Days 45.40
  • 12 Days 55.00
  • 100 Days 40.00
  • 20 Days 52.50
  • 200 Days 33.30
57.42
PIVOT
First Resistance 58.96
Second Resistance 60.95
Third Resistance 62.49
First Support 55.43
Second Support 53.89
Third Support 51.90
RSI 80.85
MACD 4.39
Commodity Channel Index (CCI) 150.51
ADX 23.50
Williams % R 0.00

Over 1 Month

down

42.19

Over 3 Months

down

94.09

Over 6 Months

down

86.35

Over 1 Year

down

57.00

Over 3 Years

down

-16.51

Over 5 Years

down

9.32

Aspira Pathlab & Diagnostics L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Aspira Pathlab & Diagnostics L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
0.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%

Aspira Pathlab & Diagnostics L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Aspira Pathlab & Diagnostics L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Aspira Pathlab & Diagnostics L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Aspira Pathlab & Diagnostics Ltd?

Answer Field

The share price of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.00 and for BSE is ₹ 61.75.

What is the Market Cap of Aspira Pathlab & Diagnostics Ltd?

Answer Field

The market cap of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 63.60 Cr. as of now.

What is the 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd?

Answer Field

The 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 62.75 and ₹ 25.00.

How to Buy Aspira Pathlab & Diagnostics Ltd share?

Answer Field

You can trade in Aspira Pathlab & Diagnostics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aspira Pathlab & Diagnostics Ltd?

Answer Field

The 1 year returns on the stock has been 57.00%.

What is the Current Share Price of Aspira Pathlab & Diagnostics Ltd?

Answer Field

Aspira Pathlab & Diagnostics Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 61.75 as on Nov 11 2024 03:26 PM.

What is the Market Cap of Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

The market cap of Aspira Pathlab & Diagnostics Ltd for NSE ₹ 0.0 & for BSE ₹ 63.60 as on Nov 11 2024 03:26 PM.

What is the P/E Ratio of Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

As on Nov 11 2024 03:26 PM the price-to-earnings (PE) ratio for Aspira Pathlab & Diagnostics Ltd share is -31.16.

What is the PB ratio of Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

As on Nov 11 2024 03:26 PM, the price-to-book (PB) ratio for Aspira Pathlab & Diagnostics Ltd share is 5.06.

How to Buy Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

You can trade in Aspira Pathlab & Diagnostics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aspira Pathlab & Diagnostics Ltd Share on Bajaj Broking App?

Answer Field

To buy Aspira Pathlab & Diagnostics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aspira Pathlab & Diagnostics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader